Table 1 Characteristics of GSE62254 and GSE29272 cohort
GSE62254 | GSE29272 | |||
|---|---|---|---|---|
Characteristic | Number of Patients (%) | Characteristic | Number of Patients (%) | |
Age (years) | Age (years) | |||
Median (Range) | 63 (24–86) | Median (Range) | 59 (23–71) | |
Gender | Gender | |||
Male | 195 (66.1%) | Male | 99 (78.6%) | |
Female | 100 (33.9%) | Female | 27 (21.4%) | |
T stage | TNMstage | |||
T2 | 184 (62.4%) | I | 5 (4.0%) | |
T3 | 90 (30.5%) | II | 5 (4.0%) | |
T4 | 21 (7.1%) | III | 108 (85.7%) | |
N stage | IV | 8 (6.3%) | ||
N0 | 38 (12.9%) | Â | Â | Â |
N1 | 128 (43.4%) | Â | Â | Â |
N2 | 79 (26.8%) | Â | Â | Â |
N3 | 50 (16.9%) | Â | Â | Â |
M stage | Â | Â | Â | |
M0 | 268 (90.8%) | Â | Â | Â |
M1 | 27 (9.2%) | Â | Â | Â |
TNMstage | Â | Â | Â | |
I | 30 (10.2%) | Â | Â | Â |
II | 94 (31.9%) | Â | Â | Â |
III | 95 (32.2%) | Â | Â | Â |
IV | 76 (25.8%) | Â | Â | Â |
Lauren | Â | Â | Â | |
Intestinal | 144 (48.8%) | Â | Â | Â |
Diffuse | 134 (45.4%) | Â | Â | Â |
Mixed | 17 (5.8%) | Â | Â | Â |